Irena Martin‐Kleiner

788 total citations
39 papers, 682 citations indexed

About

Irena Martin‐Kleiner is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Irena Martin‐Kleiner has authored 39 papers receiving a total of 682 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 17 papers in Organic Chemistry and 11 papers in Cellular and Molecular Neuroscience. Recurrent topics in Irena Martin‐Kleiner's work include Synthesis and biological activity (11 papers), Neuropeptides and Animal Physiology (11 papers) and Receptor Mechanisms and Signaling (7 papers). Irena Martin‐Kleiner is often cited by papers focused on Synthesis and biological activity (11 papers), Neuropeptides and Animal Physiology (11 papers) and Receptor Mechanisms and Signaling (7 papers). Irena Martin‐Kleiner collaborates with scholars based in Croatia, France and Greece. Irena Martin‐Kleiner's co-authors include Marijeta Kralj, Jelka Gabrilovac, Koraljka Gall‐Trošelj, Marijana Hranjec, Milivoj Boranić, Grace Karminski‐Zamola, Marie‐Hélène David‐Cordonnier, Raja Nhili, Ivana Perković and Branka Zorc and has published in prestigious journals such as Scientific Reports, Annals of the New York Academy of Sciences and The Journal of Organic Chemistry.

In The Last Decade

Irena Martin‐Kleiner

39 papers receiving 662 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Irena Martin‐Kleiner Croatia 15 301 270 80 62 38 39 682
Alessandro Balbi Italy 15 371 1.2× 270 1.0× 72 0.9× 11 0.2× 30 0.8× 29 845
Michael J. Stocks United Kingdom 23 698 2.3× 800 3.0× 182 2.3× 72 1.2× 117 3.1× 81 1.6k
Gajendra Kumar Azad India 19 171 0.6× 600 2.2× 70 0.9× 21 0.3× 47 1.2× 47 1.1k
Yaoquan Liu United States 19 147 0.5× 647 2.4× 50 0.6× 15 0.2× 37 1.0× 33 1.0k
Raphaël Rahmani Australia 14 257 0.9× 503 1.9× 104 1.3× 172 2.8× 10 0.3× 25 937
Mirjana Djukić Serbia 14 208 0.7× 243 0.9× 59 0.7× 16 0.3× 83 2.2× 40 725
Venugopal Gudipati United States 14 206 0.7× 383 1.4× 136 1.7× 14 0.2× 81 2.1× 24 826
David H. Kinder United States 16 140 0.5× 398 1.5× 111 1.4× 61 1.0× 51 1.3× 40 764
T. R. BEATTIE United States 8 200 0.7× 340 1.3× 84 1.1× 51 0.8× 69 1.8× 10 602
Jianbing Jiang Netherlands 19 449 1.5× 604 2.2× 65 0.8× 115 1.9× 16 0.4× 36 920

Countries citing papers authored by Irena Martin‐Kleiner

Since Specialization
Citations

This map shows the geographic impact of Irena Martin‐Kleiner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irena Martin‐Kleiner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irena Martin‐Kleiner more than expected).

Fields of papers citing papers by Irena Martin‐Kleiner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irena Martin‐Kleiner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irena Martin‐Kleiner. The network helps show where Irena Martin‐Kleiner may publish in the future.

Co-authorship network of co-authors of Irena Martin‐Kleiner

This figure shows the co-authorship network connecting the top 25 collaborators of Irena Martin‐Kleiner. A scholar is included among the top collaborators of Irena Martin‐Kleiner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irena Martin‐Kleiner. Irena Martin‐Kleiner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Piantanida, Ivo, Aleksey Vasilev, Mihail Mondeshki, et al.. (2021). Polycationic Monomeric and Homodimeric Asymmetric Monomethine Cyanine Dyes with Hydroxypropyl Functionality—Strong Affinity Nucleic Acids Binders. Biomolecules. 11(8). 1075–1075. 7 indexed citations
2.
Zahirović, Adnan, Aleksandar Višnjevac, Dijana Žilić, et al.. (2021). Copper(II) salicylideneimine complexes revisited: From a novel derivative and extended characterization of two homologues to interaction with BSA and antiproliferative activity. Inorganica Chimica Acta. 525. 120460–120460. 10 indexed citations
3.
Perin, Nataša, et al.. (2018). Synthesis and Antiproliferative Activity of Novel 2-Substituted N-Methylated Benzimidazoles and Tetracyclic Benzimidazo [1,2-a]Quinolines. Polycyclic aromatic compounds. 40(2). 343–354. 10 indexed citations
4.
Car, Željka, et al.. (2017). In vitro antiproliferative study of novel adamantyl pyridin-4-ones. Molecular Diversity. 21(4). 881–891. 4 indexed citations
5.
Perin, Nataša, Irena Martin‐Kleiner, Marijeta Kralj, et al.. (2017). Synthesis and antiproliferative activity of amino-substituted benzimidazo[1,2- $${\varvec{a}}$$ a ]quinolines as mesylate salts designed by 3D-QSAR analysis. Molecular Diversity. 21(3). 621–636. 8 indexed citations
6.
Perin, Nataša, Raja Nhili, Branimir Bertoša, et al.. (2016). Amino substituted benzimidazo[1,2- a ]quinolines: Antiproliferative potency, 3D QSAR study and DNA binding properties. European Journal of Medicinal Chemistry. 122. 530–545. 52 indexed citations
7.
Perković, Ivana, Irena Martin‐Kleiner, Marijeta Kralj, et al.. (2014). Novel semicarbazides and ureas of primaquine with bulky aryl or hydroxyalkyl substituents: Synthesis, cytostatic and antioxidative activity. European Journal of Medicinal Chemistry. 86. 502–514. 31 indexed citations
8.
Perković, Ivana, Ivan Butula, Marijeta Kralj, et al.. (2012). Novel NSAID 1-acyl-4-cycloalkyl/arylsemicarbazides and 1-acyl-5-benzyloxy/hydroxy carbamoylcarbazides as potential anticancer agents and antioxidants. European Journal of Medicinal Chemistry. 51. 227–238. 37 indexed citations
9.
Kraljević, Tatjana Gazivoda, et al.. (2011). Synthesis, cytostatic activity and ADME properties of C-5 substituted and N-acyclic pyrimidine derivatives. Bioorganic & Medicinal Chemistry Letters. 22(1). 308–312. 22 indexed citations
10.
Martin‐Kleiner, Irena. (2011). BORIS in human cancers – A review. European Journal of Cancer. 48(6). 929–935. 62 indexed citations
11.
Martin‐Kleiner, Irena & Koraljka Gall‐Trošelj. (2009). Mannose-6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) in carcinogenesis. Cancer Letters. 289(1). 11–22. 54 indexed citations
12.
Martin‐Kleiner, Irena, Tihomir Balog, & Jelka Gabrilovac. (2006). Signal Transduction Induced by Opioids in Immune Cells: A Review. NeuroImmunoModulation. 13(1). 1–7. 20 indexed citations
13.
Martin‐Kleiner, Irena, et al.. (2006). PMA and Doxorubicin Decrease Viability, MTT Activity and Expression of CD10 Marker on NALM-1 Leukemic Cells. Immunopharmacology and Immunotoxicology. 28(3). 411–420. 9 indexed citations
14.
Martin‐Kleiner, Irena & Jelka Gabrilovac. (2002). The κ-opioid agonist U-69593 affects intracellular calcium level in R1.1 mouse thymoma cell line. International Immunopharmacology. 2(7). 975–980. 3 indexed citations
15.
Martin‐Kleiner, Irena & Jean M. Bidlack. (1999). The synthetic κ-opioid agonist (−)U50,488 does not affect calcium transport into R1.1 mouse thymoma cell line. International Journal of Immunopharmacology. 21(2). 133–140. 4 indexed citations
16.
Martin‐Kleiner, Irena & Jelka Gabrilovac. (1997). Increase of intracellular cAMP levels in human peripheral blood mononuclear cells by Met-enkephalin. Acta Pharmaceutica. 47(1). 9–14. 2 indexed citations
17.
Martin‐Kleiner, Irena & Jelka Gabrilovac. (1996). Pretreatment of Human Peripheral Blood Lymphocytes with Interleukin-2 or Dexamethasone Does Not Alter Their Response to Met-Enkephn in A NK-Cmotoxic Assay. Immunopharmacology and Immunotoxicology. 18(1). 37–57. 5 indexed citations
18.
Martin‐Kleiner, Irena, Maja Osmak, & Jelka Gabrilovac. (1992). Regulation of NK cell activity and the level of the intracellular cAMP in human peripheral blood lymphocytes by Met-enkephalin. Research in Experimental Medicine. 192(1). 145–150. 13 indexed citations
19.
Gabrilovac, Jelka, et al.. (1992). Interaction of Leu‐Enkephalin and α‐Interferon in Modulation of NK‐Activity of Human Peripheral Blood Lymphocytes. Annals of the New York Academy of Sciences. 650(1). 140–145. 7 indexed citations
20.
Gabrilovac, Jelka, et al.. (1989). Defect of NK activity in children with untreated acute lymphocytic leukemia (ALL). I. Dependence on the blast count and phenotype, and response to exogenous and endogenous alpha-interferon.. PubMed. 29(1). 9–15. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026